Internal Medicine, Pulmonary Disease · Guayama, PR
NPI
1609950724
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
128 South, Ashford Street, Ashford Medical Plaza Suite 101
Guayama, PR, 00784
Phone (787) 864-7339
Medicare paid, 2024
$6,796
129 services
Medicare patients, 2024
34
Average age 73
Drug cost, 2024
$912K
6,341 prescriptions
Company payments, 2025
$1,153
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Buitrago was code 99213 (office e&m - established), 75 times for 29 patients. In total Juan C Buitrago billed 129 services in 12 codes, and Medicare paid $6,796.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 75 | 29 | $58.73 | $4,404 |
By year: 2022 $6,686 for 130 services; 2023 $6,202 for 122 services; 2024 $6,796 for 129 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Buitrago prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,739 prescriptions and refills. In total Juan C Buitrago wrote 6,341 Medicare prescriptions that cost $912K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,739 | 1,751 | 469 | $76K |
| Fluticasone Propionate Generic | 1,727 | 1,821 | 468 | $29K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 351 | 359 | 69 | $235K |
| Breo Ellipta Fluticasone/Vilanterol | 304 | 315 | 62 | $128K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 262 | 262 | 49 | $130K |
| Azelastine Hcl Generic | 230 | 341 | 71 | $5,305 |
| Spiriva Respimat Tiotropium Bromide | 188 | 189 | 44 | $101K |
| Montelukast Sodium Generic | 181 | 197 | 39 | $1,429 |
| Famotidine Generic | 126 | 138 | 39 | $838 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 91 | 91 | 16 | $44K |
| Desloratadine Generic | 77 | 79 | 21 | $1,955 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 75 | 75 | 18 | $20K |
| Symbicort Budesonide/Formoterol Fumarate | 61 | 61 | 28 | $13K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 59 | 15 | $7,064 |
| Ropinirole Hcl Generic | 41 | 55 | Under 11 | $359 |
Brand drugs: 3,011 claims; generic drugs: 3,330 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Buitrago $1,153 ($1,153 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $413.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.